Litcius/Paper detail

Synergistic Antiproliferative Effects of All‐Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells

Que Thanh Thanh Nguyen, Thi Xoan Hoang, Hyunjin Ryu, Kook‐Hwan Oh, Jae Young Kim

2021BioMed Research International16 citationsDOIOpen Access PDF

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by uncontrollable epithelial cell growth, cyst formation, and kidney malfunction. In the present study, we investigated the antiproliferative effects of the treatment with the combination of paclitaxel (PAC) and all‐trans retinoic acid (ATRA) on ADPKD epithelial cells. Our results show that the combined treatment with 1 nM PAC and 10 nM ATRA significantly suppressed ADPKD cell proliferation (20%), while the treatment with ATRA or PAC alone had no such effect. Treatment with PAC and ATRA induced cell cycle arrest at the G2/M phase and apoptosis by upregulating p53 and caspase‐8 expression and increased the intracellular calcium (Ca 2+ ) level possibly by enhancing Ca 2+ uptake via plasma membrane channels. In addition, this treatment suppressed extracellular signal‐regulated kinase signaling possibly through mitogen‐activated protein kinase phosphatase‐1 activation. Thus, the combination of PAC and ATRA can be explored as a potential treatment regimen for ADPKD.

Topics & Concepts

Autosomal dominant polycystic kidney diseaseRetinoic acidPolycystic kidney diseaseCancer researchApoptosisCell cycleCell growthCell biologyKinaseIntracellularChemistryInternal medicineEndocrinologyBiologyKidneyMedicineBiochemistryGeneGenetic and Kidney Cyst DiseasesBiomedical Research and PathophysiologyHedgehog Signaling Pathway Studies
Synergistic Antiproliferative Effects of All‐Trans Retinoic Acid and Paclitaxel on Autosomal Dominant Polycystic Kidney Disease Epithelial Cells | Litcius